Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines

• Viral lineages that escape antibodies have changed the landscape of the pandemic. • SARS-CoV-2 specific T cells effectively protect against disease development. • Vaccine efficacy should be evaluated by its ability to protect from severe disease. • Inactivated SARS-CoV-2 vaccine induces a multi-pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Anthony T., Lim, Joey Ming Er, Bertoletti, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wuhan Institute of Virology, Chinese Academy of Sciences 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639404/
https://www.ncbi.nlm.nih.gov/pubmed/36356859
http://dx.doi.org/10.1016/j.virs.2022.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639404/
https://www.ncbi.nlm.nih.gov/pubmed/36356859
http://dx.doi.org/10.1016/j.virs.2022.11.002

Ejemplares similares